AMP — Ameriprise Financial, Inc.

As of 2026-10-04, the market mood is cautious but not bearish: AMP is down 11.04% in one month, RSI is 30.38, and price sits 6.76% below its 20-day and 9.67% below its 50-day SMA. Analysts remain mixed-to-positive (11 buy/strong buy, 10 hold, 1 sell; consensus Buy) with targets of $556.67-$572.50, implying double-digit upside, while the fresh $5.5B buyback and continued advisor recruiting support the longer-term case.

Revenue has re-accelerated: Q2 2026 revenue was $5.013B, up 11.6% YoY from $4.494B, following +9.0% in Q1 2026, +8.3% in Q4 2025, and +6.3% in Q3 2025. Earnings are more volatile because of insurance/annuity and market-sensitive items, but the direction is positive: Q2 2026 net income rose 5.0% YoY to $1.113B, with diluted EPS up 11.6% to $11.98 due to buybacks; Q1 2026 EPS jumped to $9.68 from $5.83 a year earlier, and Q3 2025 EPS was $9.33 versus $5.00 in Q3 2024. Operating margin was 30.4% in Q2 2026 versus 31.9% in Q2 2025, a modest YoY dip, but well above the depressed 17.1% in Q1 2025 and 16.0% in Q3 2024. Free cash flow is lumpy but robust, with $2.849B in Q2 2026 and roughly $8.06B over the trailing four quarters. This looks like an inflecting, not deteriorating, trend.

As of 2026-10-04, AMP looks cheap versus its own history. The TTM P/E is 11.68x versus a 5-year average of 13.73x, and the forward P/E on next-FY EPS of $46.427 is only about 10.6x. The PEG ratio is 0.409, P/S is 2.226x versus a 5-year average of 2.61x, and the dividend yield is 1.196%. P/B is high at 7.08x, but that is distorted by buybacks shrinking book equity, so it is not the best valuation lens here. The main caveat is the low 2.0% ROIC, which reflects the balance-sheet-heavy financial model and makes the equity look less capital-efficient on that metric.

At roughly 10.6x forward EPS as of 2026-10-04, the market is pricing in cyclical risk, rate/equity-market sensitivity, and skepticism about the durability of recent margin gains. It is not pricing in much of the $5.5B buyback, which equals about 12.5% of the current market cap and should materially reduce share count through 2028, nor the recent revenue acceleration. If Q3 2026 shows stable net flows, advisor growth, and no negative insurance surprises, the multiple could re-rate toward 12-13x forward earnings and push the stock toward the $560-$600 zone. If equity markets fall or net interest income compresses, EPS estimates could be trimmed and the low multiple may persist.

As of 2026-10-04, the technical setup is short-term oversold but not yet repaired. RSI(14) was 30.38, price was 6.76% below the 20-day SMA and 9.67% below the 50-day SMA, and only 0.45% below the 200-day SMA. That implies the longer-term trend is roughly flat while the one-month move has been sharply negative. For an entry-minded investor, this is a watch-for-stabilization setup rather than a clean momentum buy; a reclaim of the 200-day SMA and then the 50-day SMA would improve the timing case, while a break below the $422-$450 area would weaken it.

• Interest rate path and long-term Treasury yields affect net interest income from cash sweep balances and the attractiveness of fixed-income products.
• Equity market performance drives fee-based advisory revenue and AUM at Advice & Wealth Management and Columbia Threadneedle.
• Regulatory scrutiny of wealth management, fiduciary standards, and insurance/annuity products can raise compliance costs or alter product economics.
• Competition for high-net-worth advisors remains intense, with wirehouses and RIAs fighting for the same talent and client assets.
• Credit and capital-market conditions influence insurance reserves, annuity hedging costs, and the pace of portfolio de-risking.

• Q3 2026 earnings on 2026-10-29, with focus on organic advisor growth, net flows, margins, and capital deployment.
• Execution of the newly authorized $5.5B share repurchase program through September 2028.
• Continued recruiting of high-producing advisors from wirehouses and other competitors.
• Improved equity markets and stable-to-higher long-term rates, which would support AUM-based fees and net interest income.
• Potential multiple re-rating if AMP sustains double-digit revenue growth and demonstrates less earnings volatility from insurance/annuity exposure.

• A sharp equity market decline would reduce AUM, advisory fees, and asset management revenue, pressuring earnings and the multiple.
• Falling interest rates or a flatter yield curve could compress net interest income from cash sweep and banking operations.
• Insurance and annuity reserves remain exposed to market, mortality, and hedging risks despite ongoing de-risking.
• The high P/B ratio and low ROIC limit the margin of safety if earnings quality or capital returns slow.
• Regulatory changes or advisor attrition could undermine the wealth management growth engine.

AMP is a well-run, capital-light-leaning financial services compounder trading at a discounted 10.6x forward P/E with accelerating revenue, strong free cash flow, and a large buyback. The recent 11% one-month selloff has made the technical picture oversold, but not broken, and the fundamental trend still looks positive. I lean bullish on a 12-18 month view, though the stock is macro-sensitive and the low ROIC/high P/B mean it is not a screaming deep-value bargain.

I apply a 12.6x forward P/E to next-FY EPS of $46.427. This multiple is a discount to AMP's 5-year average TTM P/E of 13.73x, reflecting rate/equity-market sensitivity, but a premium to the current 10.6x forward multiple given accelerating revenue, strong FCF, and the $5.5B buyback.